KMID : 0368120190490121123
|
|
Korean Circulation Journal 2019 Volume.49 No. 12 p.1123 ~ p.1135
|
|
Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension
|
|
Kario Kazuomi
|
|
Abstract
|
|
|
The new 2019 Japanese Society of Hypertension (JSH) guidelines for the management of hypertension are now available; these update the previous guidelines published in 2014. The primary objective of the guideline is to provide all healthcare professionals with a standard management strategy and appropriate antihypertensive treatments to prevent hypertension-related target organ damage and cardiovascular events. The major changes in the new guideline relate to the definition of normal blood pressure (BP) and target BP. The terms ¡®normal BP¡¯ and ¡®high normal BP¡¯ used in the JSH 2014 guidelines are replaced with terms ¡®high normal BP¡¯ and ¡®elevated BP,¡¯ respectively. There was no change to the office BP diagnostic threshold for hypertension (140/90 mmHg). Recommended target office and home BP values for patients with hypertension aged <75 years and/or high-risk patients are <130/80 mmHg and <125/75 mmHg, respectively. Corresponding targets for elderly patients with hypertension (age¡Ã75 years) are 140/90 and 135/85 mmHg, respectively. The goal is that these changes will contribute to reducing cardiovascular events, especially stroke and heart failure, in Japan. The dissemination of the JSH 2019 guidelines and implementation of a home BP-based approach by all general practitioners in Japan might be facilitated by digital hypertension management using health information technology.
|
|
KEYWORD
|
|
Hypertension, Evidence-based practice, Antihypertensive agents, Japan
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|